U.S. PHARMACOPEIA

Search USP29  
Methyclothiazide
Click to View Image
C9H11Cl2N3O4S2 360.24

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide, (±)-.
(±)-6-Chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide [135-07-9].
» Methyclothiazide contains not less than 97.0 percent and not more than 102.0 percent of C9H11Cl2N3O4S2, calculated on the dried basis.
Packaging and storage— Preserve in well-closed containers.
Identification—
Solution: 20 µg per mL.
Medium: methanol.
C: Fuse about 100 mg of it with a pellet of sodium hydroxide: the ammonia fumes produced turn moistened red litmus paper blue. The fused mixture responds to the test for Sulfite 191.
Loss on drying 731 Dry it at 105 for 4 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.2%.
Chloride 221 Shake 750 mg with 25 mL of water for 2 minutes, filter through a suitable membrane filter, and add 4 or 5 drops of 2 N nitric acid: the acidified filtrate shows no more chloride than corresponds to 0.20 mL of 0.020 N hydrochloric acid (0.02%).
Selenium 291: 0.003%.
Heavy metals, Method II 231: 0.002%.
Diazotizable substances
Standard preparation— Transfer about 10 mg of USP Methyclothiazide Related Compound A RS, accurately weighed, to a 50-mL volumetric flask, dilute with acetonitrile to volume, and mix. Pipet 25 mL of the solution into a 100-mL volumetric flask, dilute with acetonitrile to volume, and mix. Each mL of Standard preparation contains about 50 µg of the Reference Standard.
Test preparation— Transfer about 500 mg of Methyclothiazide, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with acetonitrile to volume, and mix.
Procedure— Pipet 2 mL each of the Standard preparation and the Test preparation into separate 50-mL volumetric flasks. Pipet 2 mL of acetonitrile into a third 50-mL flask to provide the blank. To each flask add 4 mL of 0.1 N hydrochloric acid, and mix. Add 3.0 mL of sodium nitrite solution (1 in 200) to each flask, mix, and place the flasks in an ice bath for 5 minutes, shaking occasionally. Add to each flask 3.0 mL of ammonium sulfamate solution (1 in 50), mix, and allow the flasks to remain in the ice bath for 1 additional minute. Remove the flasks from the ice bath, add 1.0 mL of N-(1-naphthyl)ethylenediamine dihydrochloride solution (1 in 1000), and mix. Allow the flasks to stand at room temperature for 1 minute, then dilute with water to volume, and mix. Concomitantly determine the absorbances of the solutions obtained from the Standard preparation and the Test preparation in 1-cm cells at 525 nm, with a suitable spectrophotometer, using the reagent blank to set the instrument. The absorbance of the solution from the Test preparation does not exceed that of the solution from the Standard preparation, corresponding to not more than 1.0% of diazotizable substances.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— Transfer about 350 mg of Methyclothiazide, accurately weighed, to a 250-mL conical flask, add 40 mL of a 1 in 20 solution of potassium hydroxide in methanol, and reflux at full boil for 1 hour. Cool, rinse the inner walls of the condenser with 20 mL of water and two 20-mL portions of methanol, add 10 mL of glacial acetic acid and 2 drops of eosin Y TS, and titrate with 0.1 N silver nitrate VS to the first appearance of a definite pink color. Each mL of 0.1 N silver nitrate is equivalent to 36.02 mg of C9H11Cl2N3O4S2.
Auxiliary Information— Staff Liaison : Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (MDCV05) Monograph Development-Cardiovascular
USP29–NF24 Page 1391
Phone Number : 1-301-816-8305